Quick answers
- What is Vecuronium bromide used for?
- The FDA-approved label (Vecuronium Bromide, HF Acquisition Co LLC, DBA HealthFirst, August 3, 2026) says: “Vecuronium bromide is indicated as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Vecuronium bromide have a boxed warning?
- The label we quote has no boxed warning, but 9 of 11 FDA labels for this medicine do. Check the label of your own product.
- Is there a shortage of Vecuronium bromide?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
- Has Vecuronium bromide been recalled?
- FDA enforcement reports list 2 recalls of products of this medicine; the newest started January 3, 2019 (Class I). A recall usually concerns specific lots, not every product.
- Who makes Vecuronium bromide?
- 10 companies list prescription products of Vecuronium bromide in the FDA NDC Directory, including Eugia US LLC, Mullan Pharmaceutical Inc. and Hikma Pharmaceuticals USA Inc..
What Vecuronium bromide is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
Vecuronium bromide is indicated as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.
— FDA label: Vecuronium Bromide, HF Acquisition Co LLC, DBA HealthFirst, effective August 3, 2026. Read the full label on DailyMed →
The FDA has 11 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
The label quoted above has no boxed warning.
9 of 11 FDA labels for this medicine have a boxed warning.
Forms and how it is given
| Dosage forms | Injection, powder, lyophilized, for solution · Injection, powder, for solution · Injection |
|---|---|
| Route | Intravenous |
| Prescription products | 18 in the FDA NDC Directory |
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- Eugia US LLC4 products
- Mullan Pharmaceutical Inc.2 products
- Hikma Pharmaceuticals USA Inc.2 products
- Gland Pharma Limited2 products
- Sagent Pharmaceuticals2 products
- HF Acquisition Co LLC, DBA HealthFirst2 products
- Mylan Institutional LLC2 products
- Meitheal Pharmaceuticals Inc.2 products
- Phlow Corp.1 product
- Sun Pharmaceutical Industries, Inc.1 product
FDA approval history
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
Generic approvals (6)
- ANDA074688Meitheal · August 25, 1999
- ANDA079001Sun Pharm · June 17, 2009
- ANDA090243Mylan Labs Ltd · May 11, 2010
- ANDA205390Gland · May 26, 2016
- ANDA206670Eugia Pharma · December 20, 2018
- ANDA203725Hikma · July 30, 2019
Shortage status
The FDA drug shortage list does not show these products.
Recalls
From FDA enforcement reports, matched by the product’s NDC code. A recall usually covers specific lots only: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
January 3, 2019 · Class I · Terminated · D-0373-2019
Presence of Particulate Matter: Foreign matter identified as glass detected in Vecuronium Bromide for Injection.
Vecuronium Bromide for Injection 20 mg* *1mg/mL when reconstituted to 20 mL Lyophilized, 10 x 20 mg vials, Rx Only, Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway Halol-389 350, Gujarat, India. — Sun Pharmaceutical Industries, Inc.
-
January 3, 2019 · Class I · Terminated · D-0372-2019
Presence of Particulate Matter: Foreign matter identified as glass detected in Vecuronium Bromide for Injection.
Vecuronium Bromide for Injection 10 mg*, *1mg/mL when reconstituted to 10 mL Lyophilized, 10 x 10 mg vials, Rx only, Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway Halol-389 350, Gujarat, India. — Sun Pharmaceutical Industries, Inc.
What do the recall classes mean?
Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).
Official identifiers
| RxCUI (RxNorm) | 859437 |
|---|---|
| SPL set ID of the quoted label | 582c7f44-b614-18df-e063-6294a90a74b6 |
| FDA labels (SPL) | 11 |
| FDA applications | 6 ANDA |
| Active ingredients (FDA) | VECURONIUM |
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Vecuronium Bromide, HF Acquisition Co LLC, DBA HealthFirst, effective August 3, 2026; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →